Skip to main content
Frontiers in Immunology logoLink to Frontiers in Immunology
. 2021 May 13;12:700716. doi: 10.3389/fimmu.2021.700716

Corrigendum: CXCL17 Is a Specific Diagnostic Biomarker for Severe Pandemic Influenza A(H1N1) That Predicts Poor Clinical Outcome

Jose Alberto Choreño-Parra 1,2, Luis Armando Jiménez-Álvarez 2, Gustavo Ramírez-Martínez 2, Montserrat Sandoval-Vega 3, Citlaltepetl Salinas-Lara 4, Carlos Sánchez-Garibay 4, Cesar Luna-Rivero 5, Erika Mariana Hernández-Montiel 2,6, Luis Alejandro Fernández-López 1,2, María Fernanda Cabrera-Cornejo 2,6, Eduardo Misael Choreño-Parra 7, Alfredo Cruz-Lagunas 2, Andrea Domínguez 2,6, Eduardo Márquez-García 2, Carlos Cabello-Gutiérrez 8, Francina Valezka Bolaños-Morales 9, Lourdes Mena-Hernández 10, Diego Delgado-Zaldivar 10, Daniel Rebolledo-García 10, Parménides Guadarrama-Ortiz 11, Nora E Regino-Zamarripa 1,2,6, Criselda Mendoza-Milla 12, Ethel A García-Latorre 1, Tatiana Sofía Rodríguez-Reyna 13, Diana Cervántes-Rosete 13, Carmen M Hernández-Cárdenas 14, Shabaana A Khader 15, Albert Zlotnik 16, Joaquín Zúñiga 2,6,*
PMCID: PMC8158290  PMID: 34054884

An author name was incorrectly spelled as Tatiana Sofia Rodiguez-Reyna. The correct spelling is Tatiana Sofía Rodríguez-Reyna.

In the published article, there was also an error in the affiliation of Criselda Mendoza-Milla. Instead of “Laboratorio de Inmunobiología y Genética, Instituto Nacional de Enfermedades Respiratorias “Ismael Cosío Villegas”, Mexico City, Mexico”, it should be “Departamento de Fibrosis Pulmonar, Instituto Nacional de Enfermedades Respiratorias “Ismael Cosío Villegas”, Mexico City, Mexico”.

The authors apologize for these errors and state that they do not change the scientific conclusions of the article in any way. The original article has been updated.


Articles from Frontiers in Immunology are provided here courtesy of Frontiers Media SA

RESOURCES